October 18, 2018

Again Gen-Plus, like last year, attended the world´s largest Pharma event, the CPhI worldwide. As a guest at the Midas stand (our warmest thank you for the cordial welcome!) we experienced a vivid interest in our formulation development capabilities.

Most attention rece...

October 5, 2018

This is the motto that brings together clients and personnel of Gen-Plus annually to enjoy a day of discussion, exchange and networking. The entire company team meets CEOs and senior managers to present and introduce its latest scientific and technologic achievements.

P...

September 28, 2018

Since shortly Gen-Plus is registered in the CIR–program of the French government, thus providing substantial re-imbursement opportunities for R&D costs of innovative development projects.

Our French customers are sure to welcome this financial aid. For us at Gen-Plus th...

September 14, 2018

Striving continuously to expand competencies and services Gen-Plus accomplished another milestone. Effective immediately we are now able to offer clinical trial supplies complementary to our TTS and thin-film developments thus expanding our respective business activiti...

August 31, 2018

Gen-Plus really had a great year so far, actually its best after the MBO 2015. Since then we managed a full turnaround from an internal development service to a full-fledged CRDO operating in international waters. Our track records range from patent work-arounds to EU-...

August 1, 2018

Gen-Plus finishes successfully the re-qualification of its PML-installation for any types of drug products based on film technology like Oral Dispersible Films and TTS-formulations. This gives us full reach now into the Clinical Trial Sample segment which means extende...

July 25, 2018

The 2 companies Gen-Plus and DiHeSys – Digital Health Systems conducted their second workshop on precision medicine on 19./20. June in Munich. Due to its relevance the event is developing rapidly with almost doubling the participation by still keeping its top level man...

July 20, 2018

Formulations utilizing high-potent APIs is one of the Gen-Plus key competencies. Over 60 drug products of cytostatics, immunosuppressives and kinase inhibitors (OEB 4-5) were developed for customers so far. Recently the company accomplished the manufacturing permit for...

May 16, 2017

On November 1st, 2016, the project entitled “Osmoprotective Antibiotic Ionic Liquids” which isfunded by the Bayerische Forschungsstiftung started with a kick-off meeting of the involved projectpartners - the University of Würzburg, the L+S AG in Bad Bocklet and Gen-Plu...

December 21, 2016

On October 20th, the second Science Day “Novel technologies” was held at the facilities of Gen-

Plus. This event covered a wide range from novel technologies concerning pharmaceutical

development to the current change of the pharmaceuticals market towards eHealth.

The ses...

Please reload

October 18, 2018

October 5, 2018

July 20, 2018

Please reload

News
Archiv
Please reload

                 / Impressum

                 / AGB